Literature DB >> 24984322

Hyperbaric oxygen pretreatment and preconditioning.

Enrico M Camporesi, Gerardo Bosco.   

Abstract

Exposure to hyperbaric oxygen (HBO2) before a crucial event, with the plan to create a preventing therapeutic situation, has been defined "preconditioning" and is emerging as a useful adjunct both in diving medicine as well before ischemic or inflammatory events. Oxygen pre-breathing before diving has been extensively documented in recreational, technical, commercial and military diving for tissue denitrogenation, resulting in reduced post-diving bubble loads, reduced decompression requirements and more rapid return to normal platelet function after a decompression. Preoxygenation at high atmospheric pressure has also been used in patients before exposure to clinical situations with beneficial effects, but the mechanisms of action have not yet been ascertained. During the reperfusion of ischemic tissue, oxygenated blood increases numbers and activities of oxidants generated in tissues. Previous reports showed that HBO2 preconditioning caused the activation of antioxidative enzymes and related genes in the central nervous system, including catalase (CAT), superoxide dismutase and heme oxygenase-1. Despite the increasing number of basic science publications on this issue, studies describing HBO2 preconditioning in the clinical practice remain scarce. To date, only a few studies have investigated the preconditioning effects of HBO2 in relation to the human brain and myocardium with robust and promising results.

Entities:  

Mesh:

Year:  2014        PMID: 24984322

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  9 in total

1.  Hyperbaric Oxygen Preconditioning Provides Preliminary Protection Against Doxorubicin Cardiotoxicity.

Authors:  Orhan Tezcan; Oguz Karahan; Mustafa Alan; Cenap Ekinci; Celal Yavuz; Sinan Demirtas; Aysun Ekinci; Ahmet Caliskan
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

Review 2.  Therapeutic effects of hyperbaric oxygen: integrated review.

Authors:  Suman Sen; Sheuli Sen
Journal:  Med Gas Res       Date:  2021 Jan-Mar

Review 3.  Hyperbaric oxygen preconditioning: a reliable option for neuroprotection.

Authors:  Qin Hu; Anatol Manaenko; Nathanael Matei; Zhenni Guo; Ting Xu; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2016-04-04

4.  Aerospace Dermatology.

Authors:  Sandeep Arora
Journal:  Indian J Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.494

5.  Reactive oxygen species induce injury of the intestinal epithelium during hyperoxia.

Authors:  Min Zhao; Shimiao Tang; Junchi Xin; Yingliang Wei; Dongyan Liu
Journal:  Int J Mol Med       Date:  2017-11-09       Impact factor: 4.101

6.  MEK1/2 Inhibition Synergistically Enhances the Preventive Effects of Normobaric Oxygen on Spinal Cord Injury in Decompression Sickness Rats.

Authors:  Quan Zhou; Xiangyang Meng; Guoyang Huang; Hongjie Yi; Juan Zheng; Kun Zhang; Weigang Xu
Journal:  Front Physiol       Date:  2021-06-01       Impact factor: 4.566

7.  Hyperbaric oxygen treatment and nephrotoxicity induced by gentamicin in rats.

Authors:  Matitiahu Berkovitch; Yossi Shain; Eran Kozer; Michael Goldman; Ibrahim Abu-Kishk
Journal:  BMC Nephrol       Date:  2017-12-02       Impact factor: 2.388

Review 8.  An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning.

Authors:  Ciprian Hentia; Alex Rizzato; Enrico Camporesi; Zhongjin Yang; Danina M Muntean; Dorel Săndesc; Gerardo Bosco
Journal:  Brain Behav       Date:  2018-03-30       Impact factor: 2.708

9.  Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress.

Authors:  Gerardo Bosco; Giuliano Vezzani; Simona Mrakic Sposta; Alex Rizzato; Garrett Enten; Abdullah Abou-Samra; Sandro Malacrida; Silvia Quartesan; Alessandra Vezzoli; Enrico Camporesi
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.